Close Menu

Effectiveness of Combined Therapy of Sertraline and Risperidone in Treating Patient with Obsessive-Compulsive Disorder

DOI: 
10.7727/wimj.2017.062

ABSTRACT

Objective: To research the effectiveness of combined therapy of sertraline and risperidone in treating patient with obsessive-compulsive disorder (OCD).

Method: By analyzing the pathological mechanism of OCD, this paper employed combined therapy of sertraline and risperidone to treat OCD patient, and explored the clinical effect of the combined therapy.

Results: After combined therapy treatment, OCD symptoms were significantly improved. Compared with traditional therapies, the combined therapy is of more significant effect. Common adverse reactions of drug therapy mainly include intestinal discomfort, headache, insomnia, lack of strength and anxiety.

Conclusion: The combined therapy of sertraline and risperidone has advantages including sound efficacy, instant effect, high safety, and insignificant adverse reaction, which should be widely promoted.

Keywords: OCD Patient, Sertraline, Risperidone, Therapy

*Authors Contribution: The first two authors (Suping Yue and Hanwen Jiang) contributed equally to this work.

 

Accepted: 
08 Jun, 2017
PDF Attachment: 
Weight: 
0
e-Published: 11 Jul, 2017

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Top of Page